Company Data
CytoMed Therapeutics Limited
Ticker
GDTC
Current Price
$2.56 2.4%
Market Cap
$29.5M
Price Target
Refer to Report
Volume
6.9K
52wk Range
$1.2 - $4.0499
Overview
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors.